The CDC Won’t Give the Public a Full Picture of Fertility Treatment Risks
By Jackie Davalos, Rachel Adams-Heard, and Kendall Taggart,
Bloomberg
| 01. 24. 2025
For women in the US seeking fertility treatment or considering donating their eggs, there’s a fair amount of information they can find about any given clinic or hospital. They might look for data on how many egg retrievals the clinic has done or the ages of its patients. Many times they’ll want to know how often treatment resulted in the birth of a baby.
But one thing they won’t be able to find out is how often the procedure has gone wrong. That’s because while the Centers for Disease Control and Prevention discloses “success rates,” it keeps information about health complications under lock and key.
The data gap is particularly troubling at a time when fertility treatment is increasingly relying on eggs from donors. As egg-freezing technology has advanced, the number of in vitro fertilization cycles using donor eggs has grown more than 170% since 2000, catapulting the egg-banking and donation sector into a $2 billion business in the US, according to investment firm Harris Williams. In December, Bloomberg Businessweek chronicled how a burgeoning global market for human eggs can lead...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...